Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
Johnson David Michael received 57,100 Zentalis Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Jun 16, 2026 · Filed Jun 18, 2026
On Jun 16, 2026, Johnson David Michael (Director) received 57,100 Zentalis Pharmaceuticals, Inc. shares as an award, leaving 307,521 shares. Filed Jun 18, 2026 (Form 4).
- Awarded
- 57,100 shares
- Holding after
- 307,521 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Common Stock | Award | 57,100 | 307,521 | Direct |
Source
Related
- Zentalis Pharmaceuticals, Inc.
- Johnson David Michael
- Zentalis Pharmaceuticals, Inc. shareholders
- Form 4 · Bruns Ingmar · Oct 1, 2026
- Form 4 · Walters William Thurman · Aug 19, 2026
- Schedule 13G/A · Walters Group · Aug 19, 2026
- Schedule 13G/A · Barclays PLC · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026